168 related articles for article (PubMed ID: 22647697)
21. Detection and expression of human BK virus sequences in neoplastic prostate tissues.
Das D; Shah RB; Imperiale MJ
Oncogene; 2004 Sep; 23(42):7031-46. PubMed ID: 15258563
[TBL] [Abstract][Full Text] [Related]
22. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.
Norström MM; Rådestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M
Oncotarget; 2016 Apr; 7(17):23581-93. PubMed ID: 26993768
[TBL] [Abstract][Full Text] [Related]
23. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
[TBL] [Abstract][Full Text] [Related]
24. Cancer/testis antigen SPATA19 is frequently expressed in benign prostatic hyperplasia and prostate cancer.
Wong KK; Hussain FA; Loo SK; López JI
APMIS; 2017 Dec; 125(12):1092-1101. PubMed ID: 28972294
[TBL] [Abstract][Full Text] [Related]
25. Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients.
Bodaghi S; Comoli P; Bösch R; Azzi A; Gosert R; Leuenberger D; Ginevri F; Hirsch HH
J Clin Microbiol; 2009 Aug; 47(8):2577-85. PubMed ID: 19474265
[TBL] [Abstract][Full Text] [Related]
26. Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients.
Randhawa PS; Popescu I; Macedo C; Zeevi A; Shapiro R; Vats AN; Metes D
Hum Immunol; 2006; 67(4-5):298-302. PubMed ID: 16720209
[TBL] [Abstract][Full Text] [Related]
27. Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer.
Keller XE; Kardas P; Acevedo C; Sais G; Poyet C; Banzola I; Mortezavi A; Seifert B; Sulser T; Hirsch HH; Provenzano M
Oncotarget; 2015 Mar; 6(8):6459-69. PubMed ID: 25749042
[TBL] [Abstract][Full Text] [Related]
28. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
[TBL] [Abstract][Full Text] [Related]
29. A correlation study of
Gorish BMT; Ournasseir MEH; Shammat IM
Infect Agent Cancer; 2019; 14():25. PubMed ID: 31548852
[TBL] [Abstract][Full Text] [Related]
30. Increased gene expression of TGF-β in peripheral blood mononuclear cells from renal transplant patients with polyomavirus BK viremia.
Yin WY; Lee MC; Huang HB; Lu MC
Clin Transplant; 2016 Apr; 30(4):393-8. PubMed ID: 26783039
[TBL] [Abstract][Full Text] [Related]
31. Antigen specific T-cell responses against tumor antigens are controlled by regulatory T cells in patients with prostate cancer.
Hadaschik B; Su Y; Huter E; Ge Y; Hohenfellner M; Beckhove P
J Urol; 2012 Apr; 187(4):1458-65. PubMed ID: 22341271
[TBL] [Abstract][Full Text] [Related]
32. BK virus specific humoral and cell mediated immunity in allogeneic bone marrow transplant (BMT) recipients.
Drummond JE; Shah KV; Saral R; Santos GW; Donnenberg AD
J Med Virol; 1987 Dec; 23(4):331-44. PubMed ID: 2826675
[TBL] [Abstract][Full Text] [Related]
33. Lack of association between BK virus and ependymomas, malignant tumors of pancreatic islets, osteosarcomas and other human tumors.
Grossi MP; Meneguzzi G; Chenciner N; Corallini A; Poli F; Altavilla G; Alberti S; Milanesi G; Barbanti-Brodano G
Intervirology; 1981; 15(1):10-17. PubMed ID: 6268566
[TBL] [Abstract][Full Text] [Related]
34. BK virus as a potential co-factor in human cancer.
Harris KF; Chang E; Christensen JB; Imperiale MJ
Dev Biol Stand; 1998; 94():81-91. PubMed ID: 9776229
[TBL] [Abstract][Full Text] [Related]
35. BK virus as a cofactor in the etiology of prostate cancer in its early stages.
Das D; Wojno K; Imperiale MJ
J Virol; 2008 Mar; 82(6):2705-14. PubMed ID: 18160432
[TBL] [Abstract][Full Text] [Related]
36. High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes.
De Mattei M; Martini F; Corallini A; Gerosa M; Scotlandi K; Carinci P; Barbanti-Brodano G; Tognon M
Int J Cancer; 1995 Jun; 61(6):756-60. PubMed ID: 7790107
[TBL] [Abstract][Full Text] [Related]
37. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus.
Li J; Melenhorst J; Hensel N; Rezvani K; Sconocchia G; Kilical Y; Hou J; Curfman B; Major E; Barrett AJ
J Gen Virol; 2006 Oct; 87(Pt 10):2951-2960. PubMed ID: 16963754
[TBL] [Abstract][Full Text] [Related]
38. Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity.
Trydzenskaya H; Sattler A; Müller K; Schachtner T; Dang-Heine C; Friedrich P; Nickel P; Hoerstrup J; Schindler R; Thiel A; Melzig MF; Reinke P; Babel N
Transplantation; 2011 Dec; 92(11):1269-77. PubMed ID: 22124284
[TBL] [Abstract][Full Text] [Related]
39. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study.
Hrbacek J; Urban M; Hamsikova E; Tachezy R; Eis V; Brabec M; Heracek J
BMC Cancer; 2011 Feb; 11():53. PubMed ID: 21291519
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia.
Corallini A; Barbanti-Brodano G; Portolani M; Balboni PG; Grossi MP; Possati L; Honorati C; La Placa M; Mazzoni A; Caputo A; Veronesi U; Orefice S; Cardinali G
Infect Immun; 1976 Jun; 13(6):1684-91. PubMed ID: 184044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
